Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season

Assessment of the humoral immune response in children after immunization with different types of inactivated influenza vaccines in the 2019-2020 season

Causing millions of cases worldwide every year, influenza is one of the most common respiratory infections. The effectiveness of influenza vaccination and the nature of the resulting immune response may vary depending on the vaccine composition and age group. Since children are at the highest risk o...

Full description

Bibliographic Details
Main Authors:	Zh. V. Buzitskaya, A. B. Popov, E. A. Romanovskaya-Romanko, M. V. Sergeeva, E. A. Varyushina, M. K. Erofeeva, M. A. Stukova, D. A. Lioznov
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2023-06-01
Series:	Медицинская иммунология
Subjects:	inactivated influenza vaccine children adolescents antibodies hemagglutination inhibition reaction immunogenicity criteria
Online Access:	https://www.mimmun.ru/mimmun/article/view/2737

Similar Items

Influenza vaccination influencing level of specific humoral immunity in healthy individuals
by: V. Z. Krivitskaya, et al.
Published: (2022-01-01)

AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses
by: Feixia Gao, et al.
Published: (2022-10-01)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
by: Mariia V. Sergeeva, et al.
Published: (2023-11-01)

DETERMINATION OF RUBELLA HEMAGGLUTINATION INHIBITION ANTIBODY TITER IN 18 TO 25 YEARS OLD WOMEN IN TEHRAN
by: M.Nafar Abady, et al.
Published: (1980-06-01)

Humoral immunity to influenza and severe influenza cases in Russia in 2018-2019
by: T. N. Ilyicheva, et al.
Published: (2020-01-01)

Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses
by: Michael A. Carlock, et al.
Published: (2019-09-01)

Development of B-cell response during immunization with inactivated influenza vaccines "Grippol plus", "Sovigripp" and "Ultrix"
by: A.-P. S. Shurygina, et al.
Published: (2024-01-01)

Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents
by: Eun Kyeong Kang, et al.
Published: (2017-04-01)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
by: Nijalingappa K. Kalappanavar, et al.
Published: (2022-11-01)

Isolation of Influenza Virus and Isolation of Influenza Virus and Typing in 1993
by: Masoud Saboori, et al.
Published: (1995-09-01)

REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF DOMESTIC FLU-M INACTIVATED SPLIT INFLUENZA VACCINE FOR THE IMMUNIZATION OF ADULTS AGED BETWEEN 18 AND 60
by: I. V. Feldblyum, et al.
Published: (2018-10-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
by: Irina Matveeva, et al.
Published: (2022-09-01)

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
by: Yuemei Hu, et al.
Published: (2018-06-01)

COMPARATIVE EVALUATION OF SAFETY AND IMMUNOGENICITY INACTIVATED VACCINE FOR POLYOMIELITIS PREVENTION (NETHERLANDS) AND VACCINE «IMOVAX POLIO» (FRANCE) IN CHILDREN USING TRIPLE IMMUNIZATION
by: I. V. Feldblyum, et al.
Published: (2019-08-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01)

COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
by: M. I Chernikova, et al.
Published: (2015-12-01)

Immunogenicity of Catch-Up Immunization with Conventional Inactivated Polio Vaccine among Japanese Adults
by: Shinji Fukushima, et al.
Published: (2022-12-01)

Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program
by: Andrei Shanko, et al.
Published: (2020-12-01)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
by: Juan Li, et al.
Published: (2021-10-01)

Novel Inactivated Subtype B Avian Metapneumovirus Vaccine Induced Humoral and Cellular Immune Responses
by: Yuanling Bao, et al.
Published: (2020-12-01)

Comparison of DIA with hemagglutination inhibition (HI) and enzyme immunoassay (EIA) in diagnosis of Measles
by: Y Yahya Pour, et al.
Published: (2001-04-01)

Radiation-Inactivated S. gallinarum Vaccine Provides a High Protective Immune Response by Activating Both Humoral and Cellular Immunity
by: Hyun Jung Ji, et al.
Published: (2021-08-01)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
by: Shuyu Gao, et al.
Published: (2022-11-01)

Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
by: Byung Ok Kwak, et al.
Published: (2020-04-01)

The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
by: Maryam Keshtkar-Jahromi, et al.
Published: (2020-11-01)

Physico-chemical characterization of a natural agglutinin from the hemolymph of a millipede Thyropygus descriptus
by: SrMR Basil-Rose, et al.
Published: (2014-11-01)

Inactivated vaccine Covaxin/BBV152: A systematic review
by: Tousief Irshad Ahmed, et al.
Published: (2022-08-01)

Initial and severe cases of influenza in 2020-2022 and population immunity prior to epidemic season
by: N. P. Kolosova, et al.
Published: (2022-12-01)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
by: Xiaoqiang Liu, et al.
Published: (2022-11-01)

Longitudinal Assessment of Immune Responses to Repeated Annual Influenza Vaccination in a Human Cohort of Adults and Teenagers
by: Meng-Hsuan Sung, et al.
Published: (2021-03-01)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
by: Yaping Chen, et al.
Published: (2022-12-01)

Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study
by: Joanna Waldock, et al.
Published: (2021-08-01)

An antimicrobial activity of oil extracted from Saara hardwickii
by: M. Arshad, et al.
Published: (2022-02-01)

Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice
by: Seo Yeon Kim, et al.
Published: (2024-03-01)

Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study
by: Qianhui Hua, et al.
Published: (2022-08-01)

The immune response to influenza in older humans: beyond immune senescence
by: Janet E. McElhaney, et al.
Published: (2020-05-01)

Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice
by: Ana Carolina dos Reis Albuquerque Cajaraville, et al.
Published: (2022-12-01)

Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants
by: A. N. Balashov, et al.
Published: (2020-03-01)

Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
by: Yan Zhou, et al.
Published: (2023-01-01)

Comparative immune responses of pups following modified live virus vaccinations against canine parvovirus
by: Jayalakshmi Vasu, et al.
Published: (2019-09-01)